Rohit Aggarwal
@docrota
Rheumatologist, research in Myositis & Interstitial lung disease, medical director, Myositis Center, Professor of Medicine, @UPMC @pittrheum
🧬 Join us for the Myositis India Physician Webinar! Topic: DMARDs in IIM (Idiopathic Inflammatory Myopathy) 🗓️ 28 July 2025 | ⏰ 10 AM EST | 7:30 PM IST 🎙️ Dr. Eduardo Dourado & Dr. Siddharth Jain 🔗 Register: docs.google.com/forms/d/e/1FAI… #MyositisIndia #webinar
After success in RA, PsA, it's time to define & achieve remission/ low disease activity in Myositis. Here is our review on remission/low disease criteria and significant unmet need in myositis. Welcome feedback to develop & validate IIM remission ! sciencedirect.com/science/articl…
📢 Now Accepting Applications! Join the Myositis Fellowship Program at @UPMC with Dr. Rohit Aggarwal & Dr. Chester Oddis. 📍Pittsburgh | 🗓️ July 2026–June 2027 ✅ PGY-6/7 Salary + Benefits 🌎 J1 Visa support available Inquiries: [email protected] Post Rheum/Neuro/Derm/Pulm
Thanks to @jrheum for accepting the article and inviting for the interview! Truly honored our article to be picked as Editor’s Spotlight ! Special Thanks to Anushka from India and Maha from Saudi - the emerging leaders in myositis.
Editor's Picks Spotlight Role of CD19 Chimeric Antigen Receptor T Cell Therapy in Idiopathic Inflammatory Myopathies 🖊️ Drs. Anushka Aggarwal, Maha Almackenzie and Rohit Aggarwal @Anushka2k7 @docrota 📖 jrheum.org/cgi/content/fu… 📽️ youtu.be/H2L91C4x_A0
Thanks to @jrheum for Editor’s choice to our article on CAR-T in Myositis! Watch our full interview by Dr. Earl Silverman from J Rheum
Editor's Choice: Find our recent interview discussing the role of CAR T-cell therapy in myositis with Dr Earl Silverman from Journal of Rheumatology! 😀📞📽💡 Do check out the full article in Editor's pick spotlight! @docrota @jrheum jrheum.org/content/viewin…
Looking forward to meet friends and colleagues at EULAR @eular_org ! See you in Barcelona! Will be there June 10-15.
Dear Friends — Looking for a senior PhD-level Biostatistician (Europe/USA) for a global, prestigious, high-impact international project on Myositis. Funding is provided. Interested or know someone? 📩 [email protected]
🎉 We’re pleased to announce our partnership with the Myositis Support and Understanding Association (MSU)!.🤝Together, we aim to strengthen support, promote education, and collaborate on the development of clinical trials in myositis. 🌍💙 #MCTC #MSU #Myositis #ClinicalTrials
Anti-synthetase syndrome (ASyS): Consensus on nomenclature and abbreviation for anti-synthetase syndrome is now done. Everyone should use this nomenclature and abbreviation for the ASyS going forward: an IMACS project academic.oup.com/rheumatology/a…
Dear Friends, A DCT - Decentralized Clinical Trials or Studies are not only possible but likely superior in recruitment esp for rare diseases such as myositis. See this article on recruitment rate comparison between a virtual tele-research cohort and a traditional center-based…
Everyone in CTD-ILD world, please see this paper on Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD), a RCT in IIM-ILD. Even though primary outcome was not met, but PFTs and HRCT trends before and after Abatacept are interesting and…
Dear Friends welcome budding rheumatology, pulmonary fellows, dermatology, neurology residents with interest in myositis to apply for UPMC Myositis Fellowship for July 2026-June 2027. See latest news from @UPMCPhysicianEd UPMC's Myositis Fellowship Program upmcphysicianresources.com/news/040425-my…
Join tomorrow (13Mar, 11amEST, 3pmGMT, 8.30pmIST) for “Navigating Myositis Auto-antibodies: Accuracy, Challenges, & Advances.” By distinguished experts: Dr. K.G. Chengappa (India) & Dr. Sarah Tansley (U.K.). Register: docs.google.com/forms/d/e/1FAI… Join here: us06web.zoom.us/j/85460286234?…
Dear Friends - Please join Myositis Clinical trial Consortium (MCTC) if you are interested in Myositis! Take a quick survey to be part of MCTC and collaborate in myositis studies ! We have 10 exciting global myositis project coming up in 2025 !
4/5 Take a quick survey to share your expertise and learn how you can get involved in this important initiative. 📝➡️ redcap-std.hs.pitt.edu/redcap/surveys…
🧵 1/6 | 🚨 Exciting News! We are delighted to announce our new partnership with the International Myositis Society (iMyoS)! 🤝 Together, we aim to enhance clinical trials, improve myositis patient care, and accelerate research and education worldwide. 🌍💪.
5/5 | 📲 Stay Updated: Follow us for more research and clinical trial news! #MCTC #Myositis #ClinicalTrials #Research #IIM
4/5 | 🌐 Impact: MCTC sets new standards for IIM clinical trials by promoting evidence-based treatments and enhancing trial readiness.
🧵 1/5 | 🚨 New Publication Alert! Our latest study in Clinical and Experimental Rheumatology highlights MCTC’s efforts to advance clinical trials for idiopathic inflammatory myopathies (IIM).📖 Read more: clinexprheumatol.org/abstract.asp?a…
📢 Join Physician Webinar! 🩺 Myositis India invites you to an insightful session on “Navigating Myositis Auto-antibodies: Accuracy, Challenges, and Advances.” By distinguished experts: Dr. K.G. Chengappa (India) & Dr. Sarah Tansley (U.K.). Register here: forms.gle/nrVnJ2xzoGEcUn…
